Related Articles
β‑adrenergic receptor activation promotes the proliferation of HepG2 cells via the ERK1/2/CREB pathways
β2‑adrenergic receptor expression and the effects of norepinephrine and propranolol on various head and neck cancer subtypes
Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner
Effect and mechanism of propranolol on promoting osteogenic differentiation and early implant osseointegration
β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms